Pliant Therapeutics (PLRX) Shares Outstanding (2019 - 2026)

Pliant Therapeutics (PLRX) has 8 years of Shares Outstanding data on file, last reported at $61.9 million in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $61.9 million, up 0.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $61.9 million (up 0.86% YoY), and the FY2025 annual result was $61.4 million, up 0.97% from the prior year.
• Shares Outstanding rose to $61.9 million in Q1 2026 per PLRX's latest filing, from $61.4 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $61.9 million in Q1 2026 and troughed at $36.2 million in Q1 2022.
• A 5-year average of $56.4 million and a median of $60.3 million in 2024 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding jumped 63.68% in 2023, then gained 0.86% in 2026.
• A 5-year view of Shares Outstanding shows it stood at $48.9 million in 2022, then grew by 22.43% to $59.9 million in 2023, then grew by 1.57% to $60.9 million in 2024, then grew by 0.97% to $61.4 million in 2025, then grew by 0.76% to $61.9 million in 2026.
• Business Quant data shows PLRX's Shares Outstanding at $61.9 million in Q1 2026, $61.4 million in Q4 2025, and $61.4 million in Q3 2025.